Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP241863.RARME6DEuOiWZRzLkrAiCGPXLEBaPl9s4zESN-ak2tIMs130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241863.RARME6DEuOiWZRzLkrAiCGPXLEBaPl9s4zESN-ak2tIMs130_provenance.
• NP885155.RAA5YB1IpwVGUiqw4NiJo_GEKJiw-ORj1_hSjJ-fk85vI130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885155.RAA5YB1IpwVGUiqw4NiJo_GEKJiw-ORj1_hSjJ-fk85vI130_provenance.
• NP163361.RATZNYsK0jSLcpNlNJqCsO4MJkeI5Z2mkHBr6PEebERTE130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163361.RATZNYsK0jSLcpNlNJqCsO4MJkeI5Z2mkHBr6PEebERTE130_provenance.
• NP849765.RABaKrlnLTplTQgp-pQJ62C4MWhNWuoCMPa1lxbdLNw-8130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849765.RABaKrlnLTplTQgp-pQJ62C4MWhNWuoCMPa1lxbdLNw-8130_provenance.
• NP692869.RAtwndM9cpvhy6B4W5NyOmm1G02nMEBPOF_6IpOavJN48130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692869.RAtwndM9cpvhy6B4W5NyOmm1G02nMEBPOF_6IpOavJN48130_provenance.
• NP676355.RArC76xLm68v3PV3N-EC0G6Yw0I6TJsTYxN-dPeb-ifU4130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP676355.RArC76xLm68v3PV3N-EC0G6Yw0I6TJsTYxN-dPeb-ifU4130_provenance.
• NP354873.RAzIRYKqhuA1RzDNj0m0A4tgmGq6sRBMsNnQ60mTnFx6c130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP354873.RAzIRYKqhuA1RzDNj0m0A4tgmGq6sRBMsNnQ60mTnFx6c130_provenance.
• NP441564.RADDFiW_asEMt00WE4NghQ83ghfkKJH_kskLCSuKWEtew130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP441564.RADDFiW_asEMt00WE4NghQ83ghfkKJH_kskLCSuKWEtew130_provenance.
• NP903768.RAEP6-pNAIaJmjj_pg_S_zlnKCF5wBoruKqsEysFWXoak130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP903768.RAEP6-pNAIaJmjj_pg_S_zlnKCF5wBoruKqsEysFWXoak130_provenance.
• assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP902681.RAfXgvHD3CsWDRdF3rgMyTsa40NzKOwYu4TSZHgzf-rMg130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902681.RAfXgvHD3CsWDRdF3rgMyTsa40NzKOwYu4TSZHgzf-rMg130_provenance.
• NP1268599.RAxPPV1fVogY_1omOSi3rDqSbCoGJWltmpMYui8vFKnXY130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1268599.RAxPPV1fVogY_1omOSi3rDqSbCoGJWltmpMYui8vFKnXY130_provenance.
• NP1268602.RA0H8ICRih4UumKm2JfVOD9WuL09HFq1RpROQw4E30odg130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1268602.RA0H8ICRih4UumKm2JfVOD9WuL09HFq1RpROQw4E30odg130_provenance.
• NP1268603.RAzYw8JeIFnbY_ItUZGiuxOjPZzkiPMIYeg_P_L_xXjr8130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1268603.RAzYw8JeIFnbY_ItUZGiuxOjPZzkiPMIYeg_P_L_xXjr8130_provenance.
• NP1268601.RAaP78jFDvzWwOufkuJWdfg725UaB6vTKg8cyY1IPozS0130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1268601.RAaP78jFDvzWwOufkuJWdfg725UaB6vTKg8cyY1IPozS0130_provenance.
• assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1268600.RAIrPD1zNMDuHcQy1tTRy7kszgrz94HBVwf3jJwIsWr1Q130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1268600.RAIrPD1zNMDuHcQy1tTRy7kszgrz94HBVwf3jJwIsWr1Q130_provenance.
• NP810183.RAn4IrGsqm8ysJa6f92xME6UBN4gaDYiNv6pMawO_VWXQ130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810183.RAn4IrGsqm8ysJa6f92xME6UBN4gaDYiNv6pMawO_VWXQ130_provenance.
• NP876652.RAjdvat_Y8rnUzl3Iu8wzIzTDOLZNMDG9jFCRMgTQLReE130_assertion description "[Of 63 cholangiocarcinomas, 59 (95%) expressed p62 c-myc, 47 (75%) expressed p21 c-ras, and 46 (73%) expressed p190 c-erbB-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876652.RAjdvat_Y8rnUzl3Iu8wzIzTDOLZNMDG9jFCRMgTQLReE130_provenance.